In the world of healthcare, where policies and practices are often driven by long-standing assumptions, it's refreshing to see research that challenges these norms and offers new insights. One such area is the use of Continuous Positive Airway Pressure (CPAP) therapy for obstructive sleep apnea (OSA). The conventional wisdom has been that early nonadherence to CPAP treatment predicts long-term treatment failure, leading to strict adherence criteria, such as the Medicare policy requiring patients to use CPAP for at least four hours each night on 70 percent of nights within the first 90 days to maintain coverage.
However, a recent study presented at the ATS 2026 International Conference has turned this assumption on its head. The research, led by Dennis Hwang, MD, a sleep and pulmonary physician at Kaiser Permanente Southern California, analyzed data on over 132,000 patients treated for OSA within the Kaiser Permanente system. The findings were striking: 51 percent of patients didn't meet the 90-day Medicare criteria for continued use, yet more than one-third of these patients were still using CPAP one year later.
What's more, even those who weren't meeting the four-hour threshold were still using the devices for at least two hours a night, an amount known to improve symptoms of sleep apnea. This suggests that early nonadherence doesn't equate to treatment failure. In my opinion, this finding is particularly fascinating because it challenges a long-standing assumption in clinical practice and policy. While clinicians know that some patients take time to adapt, the scale of continued use observed in those that did not initially meet Medicare adherence was striking.
This study raises a deeper question: should we be relying solely on Medicare-defined adherence when making long-term treatment decisions? The answer, I believe, is a resounding no. The arbitrary four-hour threshold and the reliance on early CPAP use may be limiting access to effective treatment for patients who would ultimately benefit from CPAP therapy. Extending support and coverage beyond the first 90 days could help more patients achieve meaningful benefit.
From my perspective, this study highlights the importance of personalized healthcare. Each patient is unique, and what works for one may not work for another. We need to move away from one-size-fits-all policies and embrace a more nuanced approach that takes into account individual patient needs and circumstances. The future of healthcare lies in this kind of personalized, patient-centered care.
In conclusion, the findings of this study are a call to action for clinicians and policymakers. We need to reevaluate our assumptions and policies regarding CPAP therapy and consider alternative approaches that focus on patient outcomes rather than arbitrary usage thresholds. By doing so, we can ensure that more patients have access to the effective treatment they need to improve their quality of life.
